Comparison of Prostate-Specific Membrane Antigen PET/CT and Contrast-Enhanced Magnetic Resonance Imaging in Follow-up Assessment of Juvenile Nasal Angiofibroma—A Novel Pilot Study
Authors:
- 15 October 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 45 (12) , e498-e504
Abstract
Purpose/Background: The specific identification of residual/recurrent juvenile nasal angiofibroma (JNA) following surgical treatment remains difficult. Contrast MRI and CT may not enable the differentiation of tumor from postsurgical reparative tissue. Functional imaging with prostate-specific membrane antigen (PSMA) PET/CT targeting tumor-associated neovasculature has recently demonstrated universal positive uptake in primary JNA and offers promise of greater accuracy in the detection or exclusion of recurrent/residual JNA. Methods: In this prospective study, 18 postsurgical JNA patients with high suspicion for residual disease evinced by follow-up MR scan, or nasal endoscopy, or recent epistaxis during September 2018–November 2019 were included. All patients underwent head and neck spot PSMA PET/CT imaging. Postcontrast enhancement of a definite lesion was considered as a criterion for residual/recurrent tumor in contrast-enhanced MRI (CEMRI). In PSMA PET/CT, any abnormal uptake apart from physiological sites in the head and neck was considered as residual lesions. Radiological results were categorized as negative, suspicious, and residual/recurrent tumors. Any discrepancy between CEMRI and PSMA was resolved by surgical biopsies. The sensitivity, specificity, and positive and negative predictive values were separately calculated for CEMRI and PSMA PET/CT for diagnosing residual lesions. The interrater agreement κ value was also calculated. Results: On CEMRI evaluation, 14 of 18 patients had residual tumors, 2 had suspicious residual lesions, and 2 had normal postoperative scans. On PSMA PET/CT, 12 of 18 patients had residual tumors, and 6 had normal negative scans. Surgical biopsy in all 4 discordant cases was negative for tumors and revealed only fibrosis. In 1 patient with residual tumor on both scans, discrepancy was noted with regard to tumor extent demonstrated by the 2 scans, and further surgical excision confirmed the imaging findings of PSMA PET/CT as accurate. The sensitivity, specificity, and positive and negative predictive values of CEMRI were 100%, 33.33%, and 75% and 100%, respectively. The sensitivity, specificity, and positive and negative predictive values of PSMA PET/CT were 100% for all parameters. The interrater agreement between the 2 tests (κ) is 0.5 (95% confidence interval, 0.19–0.81). Conclusions: The 68 Ga-PSMA PET/CT is noted as more specific than the current standard of CEMRI in the identification of residual/recurrent JNA. It is the first radionuclide imaging scan that has found application in postoperative assessment of JNA. Trial registration: Clinical Trials Registry of India (CTRI/2018/08/015479).Keywords
This publication has 16 references indexed in Scilit:
- Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to ArmsJournal of Nuclear Medicine, 2018
- Targeting PSMA by radioligands in non-prostate disease—current status and future perspectivesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Nasal juvenile angiofibroma: Current perspectives with emphasis on managementHead & Neck, 2017
- 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptideAngiogenesis, 2016
- High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavityLaboratory Investigation, 2012
- Postoperative follow-up of juvenile nasopharyngeal angiofibromas: assessment by CT scan and MR imagingEuropean Radiology, 1998
- Treatment of Large Juvenile Nasopharyngeal AngiofibromaOtolaryngology–Head and Neck Surgery, 1992
- Juvenile nasopharyngeal angiofibroma: An update of the ucla experience, 1960–1985The Laryngoscope, 1988
- Juvenile angiofibroma: imaging by magnetic resonance, CT and conventional techniquesClinical Otolaryngology, 1986